Dr. Yashwant Agrawal, MD

Dr. Agrawal practices at Dignity Health Chandler Regional Medical Center in Chandler, Arizona, part of CommonSpirit Health.

Dr. Agrawal's NPI, 1063850709, was assigned on June 4, 2013. Dr. Agrawal graduated from Western Michigan Un Homer Stryker School of Med in 2017. Dr. Agrawal holds Arizona license 62297.

Dr. Agrawal's primary practice is Dignity Health Chandler Regional Medical Center, at 1955 West Frye Road, Chandler, AZ 85224 in Maricopa County. The practice phone is (480) 728-3000.

Dr. Agrawal's primary practice is Dignity Health Chandler Regional Medical Center in Chandler, Arizona, part of CommonSpirit Health. Dr. Agrawal is also affiliated with Dignity Health Mercy Gilbert Medical Center. The medical group on file is Ibrahim Heart Clinic. Dmand AI also links Dr. Agrawal to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agrawal practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Agrawal's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Agrawal is licensed in Arizona.

CMS data shows 2,107 Medicare services from Dr. Agrawal across 22 procedure codes in 2024, for 709 Medicare patients. Medicare paid $189,298 for them.

CMS counts 709 Medicare patients who saw Dr. Agrawal in 2024. The largest group is 65 to 74, with 299 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Agrawal's median patient age at 69, with 52% women.

In 2024, Dr. Agrawal wrote 2,283 Medicare Part D claims for 586 patients. 85% of them were for generic drugs. CMS names the drug for 2,119 of them, across 28 drugs with 11 or more claims each, at $366,451 in total drug cost. In 2023, CMS named 1,957 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Agrawal for performance year 2024, reported as part of a group. Dr. Agrawal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 25 procedures of coronary angioplasty and stenting by Dr. Agrawal, more than 58% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 57 papers to Dr. Agrawal, published from 2012 to 2023. 2016 was the busiest year, with 12. The most frequent topics are Coronary Angiography, Electrocardiography and Coronary Artery Disease. Dr. Agrawal has published most often in BMJ Case Rep. Dr. Agrawal's most frequent co-authors are Vishal Gupta, MD, Dominika Maria Zoltowska, MD and Guramrinder Singh Thind, MD.

CMS Open Payments shows 110 general payments to Dr. Agrawal from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 75% of the total. Boston Scientific Corporation paid the most, $1,334.

Dr. Agrawal graduated from Western Michigan Un Homer Stryker School of Med in 2017.